PRESS RELEASE
Lonza Celebrates Opening of Niacinamide Plant in Nansha, China
ULProspector.com ResourcesPersonal Care
Food & Beverage |
Nansha, China, 5 November 2014 – Lonza Guangzhou Nansha Ltd. today celebrated the official opening of the new niacinamide plant in Nansha, China, with a launch ceremony honoring the occasion. Invited dignitaries included district and other government officials, as well as the Swiss Consul General for Guangzhou. Approximately 300 people attended the event. In addition to the crystal-ball launching ceremony, the event activities included welcome addresses, a plant tour, refreshments and traditional lion dancing.
The new niacinamide plant has been running and stable since 1 July 2014 and will satisfy the growing market demand in terms of both capacity and products. Overall, the Nansha site of Lonza covers an area of 220,000 square meters. Products and services include niacinamide (vitamin B3) (EU) and the L-Carnitine series (EU) products for both human and animal foods and supplements; hygiene and preservative series products; active pharmaceutical ingredients (APIs); chemical intermediates and custom development services.
“With our new facility, Lonza can meet growing market demands and fulfill long-term customer commitments,” said Michael Lieu, President of Lonza Greater China. “At the same time, we can reinforce our global leadership role in food, feed, pharmaceutical, cosmetic and chemical markets.”
About Lonza Guangzhou Nansha Ltd.
Established in April 2003, Lonza Guangzhou Nansha Ltd. is a high-tech company wholly owned by Lonza Group Ltd. It serves customers in both the Specialty Ingredients and Pharma & Biotech market segments. One of Lonza’s several major production, R&D and customersupport facilities in China, Lonza Guangzhou Nansha Ltd. provides products and services to China, other Asian nations and many regions around the world.
About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life. Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 10,000 employees worldwide. The company generated sales of about CHF 3.6 billion in 2013 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Lonza’s stock is publicly traded on the Swiss and the Singapore stock exchanges. Further information can be found at www.lonza.com.
Lonza Contact Information
Lonza Group Ltd Head Investor Relations Dirk Oehlers Tel +41 61 316 8540 Fax +41 61 316 9540 dirk.oehlers@lonza.com |
Lonza Group Ltd Head Corporate Communications Dominik Werner Tel +41 61 316 8798 Fax +41 61 316 9540 dominik.werner@lonza.com |
Lonza Group Ltd Head External Communications Constance Ward Tel +41 61 316 8840 Fax +41 61 316 9840 constance.ward@lonza.com |
Additional Information and Disclaimer
Lonza Group Ltd is headquartered in Basel, Switzerland, and is listed on the SIX Swiss Exchange and secondary listed on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements. Lonza Group Ltd is subject to the listing rules of the SIX Swiss Exchange, which does not have specific requirements equivalent to the listing rules of the SGX-ST for interested person transactions, acquisition and realizations and delisting.
Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release
The views, opinions and technical analyses presented here are those of the author or advertiser, and are not necessarily those of ULProspector.com or UL Solutions. The appearance of this content in the UL Prospector Knowledge Center does not constitute an endorsement by UL Solutions or its affiliates.
All content is subject to copyright and may not be reproduced without prior authorization from UL Solutions or the content author.
The content has been made available for informational and educational purposes only. While the editors of this site may verify the accuracy of its content from time to time, we assume no responsibility for errors made by the author, editorial staff or any other contributor.
UL Solutions does not make any representations or warranties with respect to the accuracy, applicability, fitness or completeness of the content. UL Solutions does not warrant the performance, effectiveness or applicability of sites listed or linked to in any content.
Leave a Reply or Comment